Efficacy of multivitamins containing phosphatidyl choline in the mananegment of hepatotoxicity from antiretroviral and/or antituberculous drugs

被引：1
|
作者：
Ladep, N. [1 ]
Shehu, N. [2 ]
Muazu, A. [2 ]
Ugoagwu, P. [2 ]
Kakjing, F. [2 ]
Badung, B. [2 ]
Daniyan, C. [2 ]
Idoko, J. [3 ]
机构：
[1] St Georges Univ, St Georges, Grenada
[2] AIDS Prevent Initiat Nigeria, Jos, Plateau, Nigeria
[3] Natl Agcy Control AIDS, Abuja, Fct, Nigeria
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2010年 / 14卷
关键词：
D O I：
10.1016/j.ijid.2010.02.2033
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E245 / E245
页数：1
相关论文
共 11 条
  • [1] The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs
    Luangchosiri, Chote
    Thakkinstian, Ammarin
    Chitphuk, Sermsiri
    Petraksa, Supanna
    Sobhonslidsuk, Abhasnee
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S993 - S994
  • [2] Treatment Literacy, Therapeutic Efficacy, and Antiretroviral Drugs: Notes from Bushbuckridge, South Africa
    Niehaus, Isak
    [J]. MEDICAL ANTHROPOLOGY, 2014, 33 (04) : 351 - 366
  • [3] Efficacy and safety of boosted and unboosted atazanavir-containing antiretroviral regimens in real life: results from a multicentre cohort study
    Giuntini, R.
    Martinelli, C.
    Ricci, E.
    Vichi, F.
    Gianelli, E.
    Madeddu, G.
    Abeli, C.
    Palvarini, L.
    Penco, G.
    Marconi, P.
    Grosso, C.
    Pellicano, G.
    Bonfanti, P.
    Quirino, T.
    [J]. HIV MEDICINE, 2010, 11 (01) : 40 - 45
  • [4] Safety and efficacy of lopinavir/ritonavir-containing antiretroviral therapy in patients aged <50 versus ≥50 years from randomized trials
    Fisher, Martin
    Norton, Michael
    Saget, Brad
    Fredrick, Linda
    van Wyk, Jean
    [J]. FUTURE VIROLOGY, 2014, 9 (04) : 351 - 362
  • [5] Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine
    Opravil, M
    Baumann, D
    Chave, JP
    Furrer, H
    Calmy, A
    Bernasconi, E
    Blasko, M
    Vernazza, P
    Ledergerber, B
    Perrin, L
    [J]. AIDS, 2004, 18 (16) : 2213 - 2215
  • [6] Does switching from multiple to single-tablet regimen containing the same antiretroviral drugs improve adherence? A group-based trajectory modeling analysis
    dos Santos, Simone Furtado
    Almeida-Brasil, Celline Cardoso
    Costa, Juliana de Oliveira
    Reis, Edna Afonso
    Cruz, Marcio Afonso
    Silveira, Micheline Rosa
    Ceccato, Maria das Gracas Braga
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2020, 32 (10): : 1268 - 1276
  • [7] Efficacy and safety of boosted and unboosted atazanavir-containing antiretroviral regimens in real life: results from a multicentre cohort study (vol 11, pg 40, 2010)
    Giuntini, R.
    Martinelli, C.
    Ricci, E.
    [J]. HIV MEDICINE, 2011, 12 (02) : 127 - 127
  • [8] Contribution of cellular HIV-1 DNA quantification to the efficacy analysis of antiretroviral therapy -: A randomized comparison of 2 regimens, including 3 drugs from 2 or 3 classes (TRIANON, ANRS 081)
    Morand-Doubert, L
    Marcellin, F
    Launay, O
    Guiraniand-Hugon, S
    Gérard, L
    Yeni, P
    Aboulker, JP
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (03) : 268 - 276
  • [9] SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen
    Campo, R.
    DeJesus, E.
    Bredeek, U. F.
    Henry, K.
    Khanlou, H.
    Logue, K.
    Brinson, C.
    Benson, P.
    Dau, L.
    Wang, H.
    White, K.
    Flaherty, J.
    Fralich, T.
    Guyer, B.
    Piontkowsky, D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (11) : 1637 - 1645
  • [10] SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen (vol 56, pg 1637, 2013)
    Campo, R.
    DeJesus, E.
    Bredeek, U. F.
    Henry, K.
    Khanlou, H.
    Logue, K.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 (05)
12